Jim Cramer says there's a tug-o-war playing out daily in the markets and investors need to keep an eye out for the 'doom-or-boom' scenario.

Real Money's Stephen "Sarge" Guilfoyle says Honeywell's recent dip offers investors a good buying opportunity.

As COVID re-emerges, Jim Cramer says it's time to look at companies that flourish in an economy that might get worse before it gets better.

Activision says people spent more time playing 'Call of Duty' in the second quarter than they did in all of 2019

San Francisco based Lyft says revenue more than doubled in latest period.

In the second quarter, Match's profit was 46 cents a share, trailing the analyst consensus.

Drugmaker focusing on non-small-cell lung cancer drug launch in second half of year.

Under Armour, ZoomInfo, Translate Bio, Outlook Therapeutics and Arcturus Therapeutics are five top gainers for Tuesday.

Stocks end higher as solid earnings reports outweigh jitters about the spread of COVID-19's delta variant and China's clampdown on its gaming and technology sectors

Clorox had a rough second quarter and Jim Cramer says big changes are needed at the consumer-products company.